June 30th, 2023

Tattooed Chef, Inc. (Nasdaq: TTCF) has announced its intention to file for Chapter 11 bankruptcy protection and pursue the sale of its assets.  Despite efforts to secure funding and reduce expenses, the company faced challenges in the financi. Read more

June 30th, 2023

Juniper Networks Inc. (NYSE: JNPR), a provider of networking solutions, was initiated for coverage by Citigroup with a Buy rating and a price target of $38.  Despite closing at $30.88 on Thursday, the stated price target suggests a potential . Read more

June 30th, 2023

Shares of Bright Health Group, Inc. (NYSE: BHG) witnessed a surge of over 20% in pre-market trading as it announced a definitive agreement with Molina Healthcare, Inc. (NYSE: MOH) to sell its California Medicare Advantage business, Brand New Day and . Read more

June 30th, 2023

Ipsen S.A. (OTCMKTS: IPSEY) and Genfit S.A. (Nasdaq: GNFT) have announced positive results from the ELATIVE Phase III trial evaluating elafibranor as a treatment for patients with primary biliary cholangitis (PBC), a rare cholestatic liver disease, w. Read more

June 30th, 2023

President Biden has announced a series of actions aimed at promoting educational opportunity and diversity in colleges and universities. The recent Supreme Court's decision in two cases — Students for Fair Admissions Inc. (SFFA) v. President an. Read more

June 29th, 2023

Shares of Renalytix plc (Nasdaq: RNLX) surged over 25% in after-hours trading following the company's announcement of receiving De Novo marketing authorization from the U.S. Food and Drug Administration (FDA) for its KidneyIntelX.dkd prognostic test.. Read more

June 29th, 2023

Shares of Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH) witnessed a significant surge of over 10% in after-hours trading, driven by the company's announcement of initiating an exploration of strategic alternatives. The Board of Aurinia will carefull. Read more

June 29th, 2023

Accolade, Inc. (Nasdaq: ACCD) released its first-quarter fiscal 2024 earnings report, revealing a loss of $0.52 per share, which was better than the consensus estimate of a loss of $0.62 per share. The company also reported quarterly sales of $93.20 . Read more

June 29th, 2023

Employee and friend traded ahead of Pfizer’s “game-changer” announcement on the success of its Paxlovid trial FOR IMMEDIATE RELEASE 2022-123 Washington D.C. / CRWE PRESS RELEASE / June 29, 2023 -  The Securities and Exch. Read more

June 29th, 2023

Shares of BioXcel Therapeutics, Inc.? (Nasdaq: BTAI) plunged by over 50% in premarket trading following the company's disclosure of a regulatory inquiry into the development of BXCL501, as revealed in a regulatory filing with the SEC. Despite this. Read more